AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Scotride M 1mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Adenscot Healthcare

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Scotride M 1mg/500mg Tablet SR

Diabexe Duo 1mg/500mg Extended-Release Tablets are classified as anti-diabetic medications. This dual-action formulation treats type 2 diabetes in adults by regulating blood glucose. Diabexe Duo should be administered with meals, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as discontinuation without medical supervision can elevate glucose levels, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication complements a comprehensive diabetes management plan incorporating a balanced diet, regular exercise, and weight management as directed by your doctor. Lifestyle modifications are essential for diabetes control. The most prevalent side effect of Diabexe Duo is hypoglycemia (low blood sugar). Learn to identify hypoglycemic symptoms like sweating, lightheadedness, headache, and tremors, and know how to manage them. Maintain consistent mealtimes and always carry a readily available fast-acting glucose source, such as sugary sweets or juice. Alcohol consumption elevates hypoglycemia risk and should be avoided. Other potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur in some individuals. This medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Disclose any history of heart disease to your doctor before commencing treatment, as it may be unsuitable. Pregnant or lactating women should consult their physician prior to use. Regular blood glucose monitoring is necessary, and your doctor may recommend blood tests to track blood cell counts and liver function.

Uses of Scotride M 1mg/500mg Tablet SR

Managing type 2 diabetes

Major Benefits of Scotride M 1mg/500mg Tablet SR:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Scotride M 1mg/500mg Extended-Release Tablets should be administered with a meal.

Common Side effects of Scotride M 1mg/500mg Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Scotride M 1mg/500mg Tablet SR:

Consume this medication precisely as prescribed by your physician, adhering to the advised dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Scotride M 1mg/500mg Sustained-Release Tablets should be administered with food.

How Scotride M 1mg/500mg Tablet SR works:

Scotride M 1mg/500mg Extended-Release Tablets combine glimepiride and metformin, two distinct antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood sugar levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, retarding intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Scotride M 1mg/500mg SR tablets is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

Use of Scotride M 1mg/500mg Tablet SR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential benefits against any risks prior to prescription. Seek medical advice.

Breast feedingBreast feedingUNSAFE

The extended-release Scotride M 1mg/500mg tablet is contraindicated for breastfeeding mothers due to potential infant toxicity.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Scotride M 1mg/500mg Tablet SR cautiously, potentially requiring dosage modification. Physician consultation is recommended. Scotride M 1mg/500mg Tablet SR is contraindicated in patients with severe kidney disease. Regular monitoring of renal function is advised during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Scotride M 1mg/500mg Tablet SR cautiously, potentially requiring dosage modification. Consult a physician. For those with mild to moderate hepatic dysfunction, initiate treatment with a low dose; the medication is contraindicated in cases of severe liver disease.

What if you forget to take Scotride M 1mg/500mg Tablet SR :

Should you forget a Scotride M 1mg/500mg SR Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Scotride M 1mg/500mg Tablet SR

LabelValue
Addictive None.
Medication Classification Medication for diabetes

FAQs on Scotride M 1mg/500mg Tablet SR

Store this medication in its original, tightly sealed container or packaging, following all storage guidelines provided on the label or packaging insert. Discard any remaining medication. Ensure the medication remains inaccessible to children, pets, and other individuals.
Indeed, Scotride M 1mg/500mg Tablet SR carries a risk of lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed Metformin-associated lactic acidosis (MALA), this rare adverse effect poses a significant threat to individuals with pre-existing kidney impairment, the elderly, or those who consume substantial alcohol. Symptoms can manifest as muscle aches or weakness, vertigo, fatigue, cold extremities, respiratory distress, nausea, emesis, abdominal discomfort, or bradycardia. The appearance of any of these necessitates immediate cessation of Scotride M 1mg/500mg Tablet SR and prompt medical attention.
Scotride M 1mg/500mg Extended-Release Tablets contain glimepiride and metformin, working synergistically to manage type 2 diabetes mellitus in adults. This dual-action therapy enhances glycemic control when coupled with a balanced diet and regular physical activity. Glimepiride stimulates pancreatic insulin secretion, thereby reducing blood glucose, while metformin decreases hepatic glucose production and boosts insulin responsiveness. This formulation is unsuitable for type 1 diabetes management.
Taking Scotride M 1mg/500mg Extended-Release Tablets may cause common side effects such as low blood sugar, taste changes, nausea, abdominal pain, diarrhea, and headache. Less frequent, but potentially severe, adverse reactions include lactic acidosis. Prolonged use might result in vitamin B12 deficiency.
Prolonged use of Scotride M 1mg/500mg SR tablets can lead to Vitamin B12 deficiency. This medication impairs Vitamin B12 absorption in the gastrointestinal tract. Untreated deficiency may result in anemia, neurological complications such as paresthesia in the extremities, weakness, urinary dysfunction, cognitive changes, and ataxia. To mitigate these risks, supplemental Vitamin B12 intake, at least annually, is recommended by some studies.
Indeed, Scotride M 1mg/500mg Extended-Release Tablets can induce hypoglycemia. Low blood sugar may manifest as nausea, headache, irritability, hunger pangs, sweating, dizziness, tachycardia, and feelings of anxiety or tremor. The risk increases with skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Consequently, consistent blood glucose monitoring is crucial. Carrying a readily available fast-acting carbohydrate source, such as glucose tablets, honey, or fruit juice, is recommended.
Combining Scotride M 1mg/500mg SR tablets and alcohol is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Scotride M 1mg/500mg Tabl...
87
MRP 107
18% off